Effects of the acute subcutaneous administration of synthetic salmon calcitonin in tumoral calcinosis.
J Endocrinol Invest
; 12(1): 55-7, 1989 Jan.
Article
em En
| MEDLINE
| ID: mdl-2745932
ABSTRACT
We examined the effects of the acute administration of salmon calcitonin on phosphate metabolism in tumoral calcinosis. On two different days, 200 MRC U of the synthetic hormone were administered sc to a 38-year-old patient, either as twice daily 100 MRC U injections, or as a continuous sc infusion via a portable pump. Both ways of calcitonin administration elicited a phosphaturic effect and a lowering of serum phosphate level comparable with that observed after an iv infusion of calcitonin. 1,25 dihydroxyvitamin D level, which was in the normal range during a control study, increased after calcitonin administration. In our patient, long term therapy with diet, a phosphate-binding agent and calcitonin prevented the occurrence of new ectopic calcifications. Owing to its phosphaturic activity, synthetic salmon calcitonin may be a useful adjunct to diet and aluminium-containing antacids in long-term management of tumoral calcinosis.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Calcinose
/
Calcitonina
/
Hormônios
Limite:
Adult
/
Female
/
Humans
Idioma:
En
Ano de publicação:
1989
Tipo de documento:
Article